Free Trial

BioSig Technologies Q3 2023 Earnings Report

BioSig Technologies logo
$1.34 +0.04 (+3.08%)
(As of 12/20/2024 05:45 PM ET)

BioSig Technologies Earnings Headlines

AI breakthrough about to upend industry
Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.
See More BioSig Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioSig Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioSig Technologies and other key companies, straight to your email.

About BioSig Technologies

BioSig Technologies (NASDAQ:BSGM), together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

View BioSig Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings